Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-210,000
Closed -$28.4M 84
2021
Q4
$28.4M Buy
210,000
+70,000
+50% +$8.27M 1.54% 24
2021
Q3
$15.1M Buy
140,000
+40,000
+40% +$4.57M 0.67% 47
2021
Q2
$11.3M Sell
100,000
-140,000
-58% -$15.8M 0.54% 53
2021
Q1
$26M Hold
240,000
1.44% 18
2020
Q4
$25.7M Buy
240,000
+70,000
+41% +$6.73M 1.76% 13
2020
Q3
$14.9M Hold
170,000
1.25% 30
2020
Q2
$16.7M Hold
170,000
1.34% 32
2020
Q1
$13M Buy
+170,000
New +$14.5M 2.61% 17

Other funds holding ABBV

SeaTown Holdings's ABBV Position: Q1 2022 in Review

SeaTown Holdings sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 210,000 shares — an estimated $28.4M sold.

SeaTown Holdings first reported a position in ABBV in Q1 2020 and held it in 8 quarters. The position peaked at $28.4M in Q4 2021. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • SeaTown Holdings reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • SeaTown Holdings sold 210,000 AbbVie shares in Q1 2022, an estimated $28.4M.
  • SeaTown Holdings first reported a position in AbbVie in Q1 2020 and held it in 8 quarters.
  • SeaTown Holdings's AbbVie position peaked at $28.4M in Q4 2021.
  • 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on SeaTown Holdings's 13F filing for Q1 2022, filed 28 Apr 2022.